<DOC>
	<DOCNO>NCT00535262</DOCNO>
	<brief_summary>This pilot study evaluate efficacy monoamine oxidase inhibitor ( MAOI ) EmSam , selegiline transdermal system ( STS ) , bipolar depression .</brief_summary>
	<brief_title>A Pilot Study Assessing EmSam Bipolar Depression</brief_title>
	<detailed_description>Most current treatment bipolar depression show modest effectiveness . There literature suggest Monoamine Oxidase Inhibitors ( MAOIs ) great efficacy tricyclic antidepressant , effective treatment-resistant depression type , unipolar bipolar . The MAOI selegiline demonstrate antidepressant efficacy . EmSam , selegiline transdermal system , provide central nervous system intestinal/liver MAO inhibition without clinically significant increase sensitivity dietary tyramine . This transdermal system appear associate few side effect increase safety relative oral MAOI 's . This pilot study evaluate efficacy EmSam bipolar depression .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Selegiline</mesh_term>
	<criteria>1 . Ages 18 65 2 . DSMIV Bipolar Disorder ( I , II , NOS ) , Depressed Phase 3 . DSMIV Bipolar Disorder ( I , II , NOS ) , Mixed state adequate mood stabilization ( ie , resolution manic hypomanic symptom 8 week minimum 4 week stable dose moodstabilizing medication continue phase study ) . 4 . Prior failure inability tolerate least one antidepressant treatment 5 . Physically healthy 6 . Agrees participate study 7 . HAMD 24 &gt; 10 1 . Bipolar Disorder ( I , II , NOS ) , Mixed State without adequate mood stabilization 2 . Prior significant adverse reaction EmSam 3 . Unstable medical disorder 4 . History epilepsy ( febrile seizure o.k . ) 5 . Current use medication might interact EnSam . 6 . Use within 2 week antidepressant medication ( 6 week fluoxetine ) 7 . Inability adhere tyraminefree diet 8 . Recent ( past 6 month ) suicide attempt 9 . Serious suicidal ideation 10 . Pregnant 11 . Breast feed 12 . Fecund , sexually active female , without adequate contraception 13 . Prior failure respond 2 adequate oral MAOI trial ( 2/3 PDR maximum dose , minimum 4 week ) 14 . Nonnicotine substance abuse/dependence within past 6 month ( 1 year amphetamines/cocaine )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Bipolar</keyword>
	<keyword>depression</keyword>
</DOC>